Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect.

Autor: Elmfeldt, D.¹, George, M.², Hübner, R.², Olofsson, B.¹

Publikováno v: Journal of Human Hypertension. Sep97 Supplement 2, Vol. 11, pS49-S53. 5p.

Cognitive function and health-related quality of life in the elderly patients with hypertension - Baseline data from the Study on Cognition and Prognosis in the Elderly (SCOPE)

Autor: Degl'Innocenti, A, Elmfeldt, D, Hansson, L, Breteler, Monique, James, O, Lithell, H, Olofsson, B, Skoog, I, Trenkwalder, P, Zanchetti, A, Wiklund, I

Publikováno v: Blood Pressure, 11, 157-165. Informa Healthcare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8a874324ee7a1ce2fb0e578ef8cd2947
https://pure.eur.nl/en/publications/3d8a6abe-3f1b-4d50-b42f-a084e8be0d04

Study on cognition and prognosis in the elderly (SCOPE): baseline characteristics

Autor: HANSSON, L., LITHELL, H., SKOOG, I., BARO, F., BANKI, C.M., BRETELER, M., CASTAIGNE, A., CORREIA, M., DEGAUTE, J.P., ELMFELDT, D., ENGEDAL, K., FARSANG, C., FERRO, J., HACHINSKI, V., HOFMAN, A., JAMES, O.F., KRISIN, E., LEEMAN, M., DE LEEUW, P.W., LEYS, D., LOBO, A., NORDBY, G., OLOFSSON, B., OPOLSKI, G., PRINCE, M., REISCHIES, F.M.

Publikováno v: Blood Pressure, 9(2-3), 146-151. Informa Healthcare
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Blood Press. 2000;9(2-3):146-51. Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics. Hansson L, Lithell H, Skoog I, Baro F, Bánki CM, Breteler M, Castaigne A, Correia M, Degaute JP, Elmfeldt D, Engedal K, Farsang C, Fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9b66c31b628f805c302ae6d599ac5951
https://pure.eur.nl/en/publications/d21d0401-f3e0-4d5d-8310-2e14554eb6d9

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

Autor: Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlof, B., Elmfeldt, D., Julius, S., Menard, J., Rahn, K. H., Wedel, H., Westerling, S., Portaluppi, Francesco

Summary Background Despite treatment, there is often a higher incidence of cardiovascular complications in patients with hypertension than in normotensive individuals. Inadequate reduction of their blood pressure is a likely cause, but the optimum ta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac71e3c1a1c64612ee6206aef00a6675
http://hdl.handle.net/11392/1207381

Metoprolol versus thiazide diuretics in hypertension: Morbidity results from the MAPHY Study

Autor: Wikstrand, J, Warnold, I, Tuomilehto, J, Olsson, G, Barber, H.J, Eliasson, K, Elmfeldt, D, Jastrup, B, Karatzas, N.B, Leer, J, Marchetta, F, Ragnarsson, J., Robitaille, N.M., Valkova, L., Wesseling, H, Berglund, G.

Publikováno v: Hypertension, 17(4), 579-588. LIPPINCOTT WILLIAMS & WILKINS

The present study in hypertensive men (40-64 years old) with untreated diastolic blood pressure above 100 mm Hg was aimed at investigating whether metoprolol (n = 1,609) given as initial treatment would lower the risk for coronary events (sudden deat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58a2b970543849e05735734c69b1f08
https://research.rug.nl/en/publications/27266c3b-966a-420c-b264-86ebae9d6005